EGFR and cancer: The acquired resistance to EGFR-TKI in intrinsic sensitive cancer cells correlated with spontaneous loss of E-cadherin, whereas the ectopic expression of E-cadherin sensitized drug-resistant cells to EGFR-TKI, accounting for a direct implication of E-cadherin in ensuing EGFR-TKI resistance.